British pharmaceutical giant GSK has committed to investing £50M (US$62.2M) over at least three years in a partnership with the University of Oxford to research vaccines that could potentially prevent cancer before it fully develops.
GSK, Oxford Launch $62M Cancer Prevention Vaccine Program